Related Experiment Video
Updated: Oct 7, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Adjunctive Catheter-Directed Thrombolysis during Primary PCI for ST-Segment Elevation Myocardial Infarction with High
Satsuki Noma1,2, Hideki Miyachi1,2, Isamu Fukuizumi1,2
1Division of Cardiovascular Intensive Care, Nippon Medical School Hospital, Tokyo 113-8603, Japan.
Insights
Catheter-directed thrombolysis (CDT) with tissue plasminogen activator is safe for ST-segment elevation myocardial infarction (STEMI) patients with high thrombus burden. It may be a valuable option when aspiration thrombectomy is unsuccessful.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Coronary Syndromes
Background:
- High coronary thrombus burden in ST-segment elevation myocardial infarction (STEMI) is linked to poor patient outcomes.
- Optimal management strategies for STEMI with high thrombus burden remain undetermined.
Purpose of the Study:
- To evaluate the safety and efficacy of adjunctive catheter-directed thrombolysis (CDT) during primary percutaneous coronary intervention (PCI) for STEMI patients with high thrombus burden.
- To assess CDT's role as a potential treatment escalation.
Main Methods:
- A retrospective analysis of 1849 STEMI patients, identifying 263 with high thrombus burden.
- Comparison of outcomes between 41 patients receiving adjunctive CDT (intracoronary tissue plasminogen activator) and 222 patients not receiving CDT during primary PCI.
- Assessment of bleeding complications, mortality, and coronary blood flow post-intervention.
Main Results:
- No significant differences in bleeding complications or in-hospital/long-term mortality between CDT and non-CDT groups.
- Lower initial post-thrombectomy coronary blood flow (Thrombolysis In Myocardial Infarction grade 2 or 3) in the CDT group (32.2%) compared to the non-CDT group (61.0%).
- Final coronary blood flow rates were similar between groups (90.3% vs. 97.4%).
Conclusions:
- Adjunctive CDT is well-tolerated and feasible in STEMI patients with high thrombus burden.
- CDT may be a beneficial therapeutic option for patients experiencing failed aspiration thrombectomy during PCI.
Background:
High coronary thrombus burden has been associated with unfavorable outcomes in patients with ST-segment elevation myocardial infarction (STEMI), the optimal management of which has not yet been established.
Methods:
We assessed the adjunctive catheter-directed thrombolysis (CDT) during primary percutaneous coronary intervention (PCI) in patients with STEMI and high thrombus burden. CDT was defined as intracoronary infusion of tissue plasminogen activator (t-PA; monteplase).
Results:
Among the 1849 consecutive patients with STEMI, 263 had high thrombus burden. Moreover, 41 patients received t-PA (CDT group), whereas 222 did not receive it (non-CDT group). No significant differences in bleeding complications and in-hospital and long-term mortalities were observed (9.8% vs. 7.2%, p = 0.53; 7.3% vs. 2.3%, p = 0.11; and 12.6% vs. 17.5%, p = 0.84, CDT vs. non-CDT). In patients who underwent antecedent aspiration thrombectomy during PCI (75.6% CDT group and 87.4% non-CDT group), thrombolysis in myocardial infarction grade 2 or 3 flow rate after thrombectomy was significantly lower in the CDT group than in the non-CDT group (32.2% vs. 61.0%, p < 0.01). However, the final rates improved without significant difference (90.3% vs. 97.4%, p = 0.14).
Conclusions:
Adjunctive CDT appears to be tolerated and feasible for high thrombus burden. Particularly, it may be an option in cases with failed aspiration thrombectomy.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

